Filing Details
- Accession Number:
- 0001415889-24-023309
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-12 17:59:12
- Reporting Period:
- 2024-09-11
- Accepted Time:
- 2024-09-12 17:59:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1699382 | Pmv Pharmaceuticals Inc. | PMVP | Pharmaceutical Preparations (2834) | 463218129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2006668 | Michael Carulli | C/O Pmv Pharmaceuticals, Inc. One Research Way Princeton NJ 08540 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-11 | 2,891 | $1.50 | 88,395 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These reported shares were sold to cover the reporting person's tax obligation in connection with the vesting of restricted stock units, or RSUs.
Billionaire Hedge Funds
